The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $30.25

Today's change-0.61 -1.98%
Updated April 28 4:03 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $30.25

Today's change-0.61 -1.98%
Updated April 28 4:03 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC crosses below 20-day moving average

AstraZeneca PLC closed sharply lower Friday, dropping (U.S.)$0.61 or 1.98% to (U.S.)$30.25 and crossing below its 20-day moving average. Over the last five days, shares have gained 1.65% and 10.72% year to date. Shares have underperformed the S&P 500 by 11.51% during the last year.

Key company metrics

  • Open(U.S.) $30.58
  • Previous close(U.S.) $30.86
  • High(U.S.) $30.65
  • Low(U.S.) $30.21
  • Bid / Ask-- / --
  • YTD % change+10.72%
  • Volume4,930,517
  • Average volume (10-day)3,456,704
  • Average volume (1-month)3,967,249
  • Average volume (3-month)5,575,931
  • 52-week range(U.S.) $25.55 to (U.S.) $35.04
  • Beta0.83
  • Trailing P/E22.59×
  • P/E 1 year forward16.29×
  • Forward PEG2.23×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield4.63%
  • Trailing EPS(U.S.) $1.34
Updated April 28 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue5,4055,5855,6995,603
Total other revenue--------
Total revenue5,4055,5855,6995,603
Gross profit4,5114,4684,8584,560
Total cost of revenue8941,1178411,043
Total operating expense4,4883,0524,6715,300
Selling / general / administrative2,3772,1331,9682,191
Research & development1,4531,4811,3371,384
Depreciation / amortization--298297309
Interest expense (income), net operating--------
Unusual expense (income)---835335765
Other operating expenses, total-236-1,142-107-392
Operating income9172,5331,028303
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5822,183676-30
Income after tax5121,817995-31
Income tax, total70366-3191
Net income5371,8421,014-3
Total adjustments to net income--------
Net income before extra. items5371,8421,014-3
Minority interest25251928
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5371,8421,014-3
Inc. avail. to common incl. extra. items5371,8421,014-3
Diluted net income5371,8421,014-3
Dilution adjustment--00--
Diluted weighted average shares1,2661,2661,2661,265
Diluted EPS excluding extraordinary itemsvalue per share0.421.450.800.00
Dividends per sharevalue per share0.001.850.000.90
Diluted normalized EPSvalue per share0.421.151.070.59